| Financial Year |
March 31 2023 |
| Monetary Funds |
278,681,220.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
34,825,818.53 |
| Advances to Suppliers |
3,592,584.34 |
| Other Receivables |
3,247,509.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
29,762,325.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,355,797.60 |
| Total Current Assets |
356,465,255.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
157,199,784.64 |
| Fixed Assetes |
494,250,398.10 |
| Under-construction Projects |
21,864,945.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,339,380.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,599,725.03 |
| Deferred Income Tax Assets |
9,209,899.25 |
| Other Non-Current Assets |
3,253,922.09 |
| Sub-Total of Non-Current Assets |
853,210,727.11 |
| Total Assets |
1,209,675,982.31 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
10,660,850.94 |
| Accounts Received In Advance |
231,574.00 |
| Employee Compensation Payable |
2,309,163.14 |
| Taxes Payable |
6,343,818.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,905,908.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
78,025.35 |
| Other Current Liabilities |
690,850.51 |
| Sub-Total of Current Liabilities |
29,047,592.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,520,909.43 |
| Total Liabilities |
47,568,501.98 |
| Paid-In Capital(Or Share Stock) |
935,625,600.00 |
| Capital Surplus |
54,952,715.98 |
| Surplus Reserve |
58,740,017.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
112,789,146.98 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,162,107,480.33 |
| Owner's Equity（Stockholder's Equity） |
1,162,107,480.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,209,675,982.31 |
